1. Home
  2. CRMD vs GAIN Comparison

CRMD vs GAIN Comparison

Compare CRMD & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • GAIN
  • Stock Information
  • Founded
  • CRMD 2006
  • GAIN 2005
  • Country
  • CRMD United States
  • GAIN United States
  • Employees
  • CRMD N/A
  • GAIN N/A
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • GAIN Finance: Consumer Services
  • Sector
  • CRMD Health Care
  • GAIN Finance
  • Exchange
  • CRMD Nasdaq
  • GAIN Nasdaq
  • Market Cap
  • CRMD 464.7M
  • GAIN 497.3M
  • IPO Year
  • CRMD 2010
  • GAIN 2005
  • Fundamental
  • Price
  • CRMD $8.50
  • GAIN $13.31
  • Analyst Decision
  • CRMD Strong Buy
  • GAIN Hold
  • Analyst Count
  • CRMD 6
  • GAIN 2
  • Target Price
  • CRMD $14.50
  • GAIN $13.75
  • AVG Volume (30 Days)
  • CRMD 2.6M
  • GAIN 159.1K
  • Earning Date
  • CRMD 05-08-2025
  • GAIN 05-13-2025
  • Dividend Yield
  • CRMD N/A
  • GAIN 11.07%
  • EPS Growth
  • CRMD N/A
  • GAIN N/A
  • EPS
  • CRMD N/A
  • GAIN 1.92
  • Revenue
  • CRMD $43,472,170.00
  • GAIN $89,176,000.00
  • Revenue This Year
  • CRMD $207.65
  • GAIN $5.92
  • Revenue Next Year
  • CRMD $50.13
  • GAIN $10.25
  • P/E Ratio
  • CRMD N/A
  • GAIN $7.07
  • Revenue Growth
  • CRMD N/A
  • GAIN 6.78
  • 52 Week Low
  • CRMD $3.61
  • GAIN $11.42
  • 52 Week High
  • CRMD $13.85
  • GAIN $14.85
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 57.04
  • GAIN 54.92
  • Support Level
  • CRMD $6.32
  • GAIN $13.43
  • Resistance Level
  • CRMD $7.71
  • GAIN $14.03
  • Average True Range (ATR)
  • CRMD 0.49
  • GAIN 0.56
  • MACD
  • CRMD 0.32
  • GAIN 0.10
  • Stochastic Oscillator
  • CRMD 97.64
  • GAIN 86.21

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to (i) achieve and grow current income by investing in debt securities of established businesses. (ii) provide our stockholders with long-term capital appreciation in the value of our assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

Share on Social Networks: